Inventor · disambiguated record
Se Chang Kwon
Also filed as: KWON SE C · KWON SE CHANG
95 granted patents·34 pending applications·674 citations·filing 1999–2022
99Inventor score
Files withHANMI PHARM IND CO LTD68HANMI SCIENCE CO LTD24JUNG SUNG YOUB6SONG DAE HAE6HANMI PHARMACEUTICAL CO LTD4
Top patents by PatentIndex Score
129 records- 0198US10370426B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Aug 6, 2019·21 cites·16 claims
- 0297US8124094B2Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the sameKIM YOUNG MIN·Filed 2005·Granted Feb 28, 2012·63 cites·13 claims
- 0396US8263084B2Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugateSONG DAE HAE·Filed 2008·Granted Sep 11, 2012·37 cites·6 claims
- 0496US7736653B2Pharmaceutical composition comprising an immunoglobulin Fc region as a carrierHANMI PHARM IND CO LTD·Filed 2004·Granted Jun 15, 2010·80 cites·13 claims
- 0596US7737260B2Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI PHARM IND CO LTD·Filed 2004·Granted Jun 15, 2010·54 cites·45 claims
- 0695US9731031B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofJUNG SUNG YOUB·Filed 2012·Granted Aug 15, 2017·16 cites·78 claims
- 0795US8110665B2Pharmaceutical composition comprising an immunoglobulin FC region as a carrierKIM YOUNG MIN·Filed 2010·Granted Feb 7, 2012·24 cites·11 claims
- 0893US10918736B2Conjugate of therapeutic enzymesHANMI PHARM IND CO LTD·Filed 2017·Granted Feb 16, 2021·8 cites·25 claims
- 0993US10894089B2Long-acting insulin or insulin analogue conjugateHANMI PHARM IND CO LTD·Filed 2016·Granted Jan 19, 2021·18 cites·15 claims
- 1093US10400020B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Sep 3, 2019·10 cites·24 claims
- 1193US8163889B2Physiologically active polypeptide conjugate having prolonged in vivo half-lifeKIM YOUNG-MIN·Filed 2009·Granted Apr 24, 2012·14 cites·17 claims
- 1292US9522946B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2015·Granted Dec 20, 2016·11 cites·5 claims
- 1391US8029789B2Method for the mass production of immunoglobulin constant regionHANMI HOLDINGS CO LTD·Filed 2004·Granted Oct 4, 2011·25 cites·12 claims
- 1490US11332508B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted May 17, 2022·2 cites·34 claims
- 1590US9981017B2Insulin conjugate using an immunoglobulin fragmentHANMI SCIENCE CO LTD·Filed 2016·Granted May 29, 2018·4 cites·21 claims
- 1690US9394546B2Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the sameHANMI PHARM IND CO LTD·Filed 2014·Granted Jul 19, 2016·8 cites·13 claims
- 1790US8476230B2Insulinotropic complex using an immunoglobulin fragmentSONG DAE HAE·Filed 2008·Granted Jul 2, 2013·18 cites·20 claims
- 1889US9527898B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameJUNG SUNG YOUB·Filed 2012·Granted Dec 27, 2016·10 cites·17 claims
- 1988US9901621B2Composition for treating hyperlipidemia comprising oxyntomodulin derivativeHANMI PHARM IND CO LTD·Filed 2016·Granted Feb 27, 2018·5 cites·15 claims
- 2088US9765131B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2016·Granted Sep 19, 2017·5 cites·7 claims
- 2188US9724420B2Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC regionHANMI PHARM IND CO LTD·Filed 2013·Granted Aug 8, 2017·9 cites·27 claims
- 2287US9636420B2Polypeptide complex comprising non-peptidyl polymer having three functional endsSONG DAE HAE·Filed 2009·Granted May 2, 2017·9 cites·24 claims
- 2387US9421244B2Long-acting interferon beta formulation comprising an immunoglobulin fragmentKIM DAE JIN·Filed 2011·Granted Aug 23, 2016·12 cites·20 claims
- 2487US7968316B2Method for the mass production of immunoglobulin Fc region deleted initial methionine residuesHANMI HOLDINGS CO LTD·Filed 2006·Granted Jun 28, 2011·9 cites·15 claims
- 2586US10981967B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted Apr 20, 2021·3 cites·41 claims
- 2686US9750820B2IgG Fc fragment for a drug carrier and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2014·Granted Sep 5, 2017·4 cites·4 claims
- 2786US9072794B2Long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesityWOO YOUNG EUN·Filed 2011·Granted Jul 7, 2015·6 cites·42 claims
- 2885US11389508B2Protein complex by use of a specific site of an immunoglobulin fragment for linkageHANMI PHARM IND CO LTD·Filed 2016·Granted Jul 19, 2022·2 cites·20 claims
- 2985US10071171B2Polypeptide complex comprising non-peptidyl polymer having three functional endsHANMI SCIENCE CO LTD·Filed 2015·Granted Sep 11, 2018·5 cites·22 claims
- 3085US9422349B2N-terminal modified exendin-4JUNG SUNG YOUB·Filed 2008·Granted Aug 23, 2016·8 cites·8 claims
- 3185US9186415B2Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragmentKIM CHANG HWAN·Filed 2011·Granted Nov 17, 2015·6 cites·19 claims
- 3284US10660940B2Preparation method for high-yield production of physiologically active polypeptide conjugateHANMI PHARM IND CO LTD·Filed 2014·Granted May 26, 2020·4 cites·28 claims
- 3384US10550168B2Composition for treating diabetes or diabesity comprising oxyntomodulin analogHANMI PHARM IND CO LTD·Filed 2018·Granted Feb 4, 2020·3 cites·10 claims
- 3484US9801950B2Liquid formulation of long acting insulinotropic peptide conjugateHANMI PHARM IND CO LTD·Filed 2013·Granted Oct 31, 2017·7 cites·26 claims
- 3584US9492507B2Insulin conjugate using an immunoglobulin fragmentSONG DAE HAE·Filed 2011·Granted Nov 15, 2016·8 cites·17 claims
- 3683US11207383B2Protein complex by use of a specific site of an immunoglobulin fragment for linkageHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 28, 2021·2 cites·22 claims
- 3783US8895281B2Method for preparing a site-specific physiologically active polypeptide conjugateSONG DAE HAE·Filed 2010·Granted Nov 25, 2014·5 cites·15 claims
- 3882US10744187B2Insulin conjugate using an immunoglobulin fragmentHANMI SCIENCE CO LTD·Filed 2018·Granted Aug 18, 2020·1 cites·18 claims
- 3982US10493132B2Composition for treating hyperlipidemia comprising oxyntomodulin derivativeHANMI PHARM IND CO LTD·Filed 2017·Granted Dec 3, 2019·2 cites·6 claims
- 4082US10046061B2Site-specific insulin conjugateHANMI PHARM IND CO LTD·Filed 2014·Granted Aug 14, 2018·6 cites·30 claims
- 4182US9789202B2Method for treating cancer using an interferon alpha conjugateJUNG SUNG YOUB·Filed 2012·Granted Oct 17, 2017·7 cites·17 claims
- 4282US7718399B2Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragmentHANMI PHARM IND CO LTD·Filed 2004·Granted May 18, 2010·6 cites·19 claims
- 4381US10279041B2Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin fragmentHANMI PHARM IND CO LTD·Filed 2017·Granted May 7, 2019·2 cites·23 claims
- 4481US9833516B2Liquid formulation of long-acting insulin and insulinotropic peptideHANMI PHARM IND CO LTD·Filed 2013·Granted Dec 5, 2017·5 cites·30 claims
- 4581US9597378B2Blood coagulation factor VII and VIIa derivatives, conjugates and complexes comprising the same, and use thereofHANMI SCIENCE CO LTD·Filed 2012·Granted Mar 21, 2017·3 cites·27 claims
- 4681US7476776B2Method for improving germline transmission efficiency of avian primordial germ cellsSEOUL NAT UNIV IND FOUNDATION·Filed 2004·Granted Jan 13, 2009·12 cites·8 claims
- 4780US10435459B2Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver diseaseHANMI PHARM IND CO LTD·Filed 2019·Granted Oct 8, 2019·2 cites·13 claims
- 4880US10363320B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofHANMI SCIENCE CO LTD·Filed 2017·Granted Jul 30, 2019·1 cites·20 claims
- 4980US7704709B2Modified human granulocyte-colony stimulating factor and process for producing sameHANMI PHARM IND CO LTD·Filed 2007·Granted Apr 27, 2010·2 cites·28 claims
- 5080US2022213164A1Triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 129 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Se Chang Kwon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →